Research and Markets: Etanercept - Eliminate Unnecessary Risk with the Industry Benchmark in Comprehensive Patent Informat

DUBLIN--(BUSINESS WIRE)-- Research and Markets(http://www.researchandmarkets.com/research/08022e/etanercept_compr) has announced the addition of the "Etanercept - Comprehensive patent search" report to their offering.

Etanercept - Eliminate unnecessary risk with the industry benchmark in comprehensive patent information

Pipeline Developer is a regularly updated, professional patent search performed by our expert team, which not only identifies relevant patents, but delivers categorisation and interpretation, all delivered by a convenient online interface.

This Pipeline Developer report covers Etanercept

Etanercept indications: Rheumatoid arthritis; Polyarticular juvenile idiopathic arthritis; Psoriatic arthritis; Ankylosing spondylitis; Plaque psoriasis; optionally in combination with Methotrexate

Etanercept innovator: Wyeth (Enbrel); Amgen (Enbrel); Immunex (Enbrel)

Imagine having your own team of pharmaceutical patent experts, at a fraction of the cost and without the wait.

Used by the worlds leading generic pharmaceutical companies and legal teams, Pipeline Developer minimises the risk of wasted developments or legal action, by providing you with nothing less than the very best in comprehensive patent information. Searched and analysed by highly trained, dedicated staff using sophisticated searching techniques, Pipeline Developer delivers results you can rely on. And that means your staff can concentrate on how the patent landscape affects your business, rather than trying to source reliable patent information.

Pipeline Developer features:

  • Comprehensive patent searching, covering the world's key territories (see 'search coverage' below)
  • Identifies patents covering molecule, formulation, process, use, combination and assay techniques (see 'Patent Categories Identified' below)
  • Patent identification, categorisation and interpretation
  • Grouped by patent family and assigned to development categories based on Interpretation of key aspects of the patent claims
  • Manual filtration of patents not relevant to generic development
  • Updated on a monthly basis, including changes to patent families, statuses, and litigation
  • Enables fast analysis and verification by hyper-linking to crucial patent documents and national registers

Patent Categories Identified:

1. Molecular Form

2. Active Ingredient Preparation

3. Formulations & Methods Thereof

4. Related Medical Use & Administration

5. Active Ingredient Combinations

6. Analytical Methods

Search coverage:

Clicking on a patent family displays detailed information on the 'Core' and 'Non-Core' 'Patent Family Equivalents'. 'Core Patent Family Equivalents' are equivalent patents from territories that are individually verified and monitored for changes, including British, German, Spanish, French, US, Canadian, Australian, European, and PCT patents. Statuses are also monitored and updated. 'Extended Patent Family Equivalents' are equivalent patents found through the INPADOC database, increasing the search coverage to 70 countries. Patent and national register access:

Clicking on a listed patent/application number or text or image link will launch a pop-up window containing an image of the patent, enabling easy analysis of the patent documents. Clicking on a register link launches a pop-up window with the patent office register extract for that patent. This allows investigation into the examination status of a pending patent, opposition of a granted patent and/or payment of maintenance fees. Please note that no extra charges apply to accessing or downloading documents of any kind.

Litigation alerts:

Informing you of developments in court, litigation alerts can also be accessed by clicking on the litigation symbol next to the status, with links to judgements where available.

Updating:

To take the time and hassle out of monitoring and updating a large number of patents, all Pipeline Developer reporting is updated on a monthly basis. Convenient change flags identify new patent families, new patent family members, changes in statuses and litigation alerts.

Legal status and transaction history:

You can also find legal status and transaction history for 'Extended Patent Family Equivalents' by clicking on the INPADOC Family/Legal Status button for 65 additional territories.

Companies Mentioned:

Wyeth (Protonix)

Altana (Protium)

Pfizer (Somac, Pantoloc)

For more information visit http://www.researchandmarkets.com/research/08022e/etanercept_compr



CONTACT:

Research and Markets
Laura Wood, Senior Manager,
[email protected]
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

KEYWORDS:

INDUSTRY KEYWORDS:   Health  Pharmaceutical  Manufacturing  Chemicals/Plastics  Medical Supplies

MEDIA:

Logo
 Logo

Suggested Articles

Bristol-Myers already has one Opdivo combo approved in kidney cancer, but it’s going for another—and new trial data could be just the ticket.

Trodelvy's bladder cancer data look weaker compared with what Seattle Genetics' rival drug Padcev achieved in its own trial.

Merck’s Keytruda is battling Bristol Myers' Opdivo in adjuvant melanoma, and it just racked up trial results that will help it even the playing field.